Natascha Mayer

Title: Natascha Mayer: Innovator in Hematology

Introduction

Natascha Mayer is a prominent inventor based in Marburg, Germany. She has made significant contributions to the field of hematology, particularly in the development of therapies related to blood coagulation disorders. Her innovative work has led to the creation of a patented concentrate that plays a crucial role in treating patients with von Willebrand disease.

Latest Patents

Natascha Mayer holds a patent for a "Concentrate of a factor VIII:C-containing von Willebrand factor and the process relating thereto." This invention focuses on a concentrate and a process for producing a factor VIII:C-containing von Willebrand factor through fractional precipitation. The resulting product boasts an increased content of high molecular weight multimers of von Willebrand factor, achieving a ratio of the vWF:RCoF activity to vWF:Ag of greater than 1. This advancement is vital for improving treatment options for patients with bleeding disorders.

Career Highlights

Natascha Mayer is currently employed at CSL Behring GmbH, a leading global biotechnology company specializing in the development of innovative therapies for rare and serious diseases. Her work at CSL Behring has allowed her to collaborate with other experts in the field, enhancing the impact of her research and inventions.

Collaborations

Throughout her career, Natascha has worked alongside notable colleagues such as Gerhardt Kumpe and Manfred Juraschek. These collaborations have fostered a dynamic environment for innovation and have contributed to the advancement of therapeutic solutions in hematology.

Conclusion

Natascha Mayer's contributions to the field of hematology through her innovative patent and work at CSL Behring GmbH highlight her dedication to improving patient care. Her research continues to pave the way for advancements in the treatment of blood coagulation disorders.